|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maddodi N and Setaluri V: Role of UV in
cutaneous melanoma. Photochem Photobiol. 84:528–536. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pessina F, Navarria P, Tomatis S, Cozzi L,
Franzese C, Di Guardo L, Ascolese AM, Reggiori G, Franceschini D,
Del Vecchio M, et al: Outcome evaluation of patients with limited
brain metastasis from malignant melanoma, treated with surgery,
radiation therapy, and targeted therapy. World Neurosurg.
105:184–190. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: microRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu WJ, Li HH, Wang Y, Zhao X, Guo Y, Jin
J and Chi R: MiR-30b-5p functions as a tumor suppressor in cell
proliferation, metastasis and epithelial-to-mesenchymal transition
by targeting G-protein subunit α-13 in renal cell carcinoma. Gene.
626:275–281. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang M, Gao C, Yang Y, Li G, Dong J, Ai
Y, Ma Q and Li W: MiR-424 promotes non-small cell lung cancer
progression and metastasis through regulating the tumor suppressor
gene TNFAIP1. Cell Physiol Biochem. 42:211–221. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peng J, Liu HL and Liu CH: MiR-155
promotes uveal melanoma cell proliferation and invasion by
regulating NDFIP1 expression. Technol Cancer Res Treat.
16:1160–1167. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu K, Jin J, Rong K, Zhuo L and Li P:
MicroRNA-675 inhibits cell proliferation and invasion in melanoma
by directly targeting metadherin. Mol Med Rep. 17:3372–3379.
2018.PubMed/NCBI
|
|
10
|
Kang K, Zhang J, Zhang X and Chen Z:
MicroRNA-326 inhibits melanoma progression by targeting KRAS and
suppressing the AKT and ERK signalling pathways. Oncol Rep.
39:401–410. 2018.PubMed/NCBI
|
|
11
|
Cao JM, Li GZ, Han M, Xu HL and Huang KM:
MiR-30c-5p suppresses migration, invasion and epithelial to
mesenchymal transition of gastric cancer via targeting MTA1. Biomed
Pharmacother. 93:554–560. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oksuz Z, Serin MS, Kaplan E, Dogen A,
Tezcan S, Aslan G, Emekdas G, Sezgin O, Altintas E and Tiftik EN:
Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p
could be used as novel non-invasive biomarkers for HCV-positive
cirrhosis and hepatocellular carcinoma. Mol Biol Rep. 42:713–720.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang SJ, Yang SY, Wang DD, Chen X, Shen
HY, Zhang XH, Zhong SL, Tang JH and Zhao JH: The miR-30 family:
Versatile players in breast cancer. Tumour Biol.
39:10104283176922042017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen C, Zhou L, Wang H, Chen J, Li W, Liu
W, Shen M, Liu H and Fu X: Long noncoding RNA CNALPTC1 promotes
cell proliferation and migration of papillary thyroid cancer via
sponging miR-30 family. Am J Cancer Res. 8:192–206. 2018.PubMed/NCBI
|
|
15
|
Polo A, Crispo A, Cerino P, Falzone L,
Candido S, Giudice A, De Petro G, Ciliberto G, Montella M, Budillon
A and Costantini S: Environment and bladder cancer: Molecular
analysis by interaction networks. Oncotarget. 8:65240–65252. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Giles KM, Brown RAM, Ganda C, Podgorny MJ,
Candy PA, Wintle LC, Richardson KL, Kalinowski FC, Stuart LM, Epis
MR, et al: microRNA-7-5p inhibits melanoma cell proliferation and
metastasis by suppressing RelA/NF-ΚB. Oncotarget. 7:31663–31680.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Varamo C, Occelli M, Vivenza D, Merlano M
and Lo Nigro C: MicroRNAs role as potential biomarkers and key
regulators in melanoma. Genes Chromosomes Cancer. 56:3–10. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Latchana N, Ganju A, Howard JH and Carson
WE III: MicroRNA dysregulation in melanoma. Surg Oncol. 25:184–189.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li M, Long C, Yang G, Luo Y and Du H:
MiR-26b inhibits melanoma cell proliferation and enhances apoptosis
by suppressing TRAF5-mediated MAPK activation. Biochem Biophys Res
Commun. 471:361–367. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu H and Yang W: MiR-211 is epigenetically
regulated by DNMT1 mediated methylation and inhibits EMT of
melanoma cells by targeting RAB22A. Biochem Biophys Res Commun.
476:400–405. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fattore L, Mancini R, Acunzo M, Romano G,
Laganà A, Pisanu ME, Malpicci D, Madonna G, Mallardo D, Capone M,
et al: miR-579-3p controls melanoma progression and resistance to
target therapy. Proc Natl Acad Sci USA. 113:E5005–E5013. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang SL, Liu Q, Zhang Q and Liu L:
MicroRNA-30a-5p suppresses proliferation, invasion and tumor growth
of hepatocellular cancer cells via targeting FOXA1. Oncol Lett.
14:5018–5026. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang CL, Cai LC, Liu J, Wang G, Li H, Wang
X, Xu W, Ren M, Feng L, Liu P and Zhang C: MicroRNA-30a-5p Inhibits
the growth of renal cell carcinoma by modulating GRP78 expression.
Cell Physiol Biochem. 43:2405–2419. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang X, Bai F, Xu Y, Chen Y and Chen L:
Intensified beclin-1 mediated by low expression of Mir-30a-5p
promotes chemoresistance in human small cell lung cancer. Cell
Physiol Biochem. 43:1126–1139. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chung YH, Li SC, Kao YH, Luo HL, Cheng YT,
Lin PR, Tai MH and Chiang PH: MiR-30a-5p inhibits
epithelial-to-mesenchymal transition and upregulates expression of
tight junction protein claudin-5 in human upper tract urothelial
carcinoma cells. Int J Mol Sci. 18:pii: E1826. 2017. View Article : Google Scholar
|
|
27
|
Liu Y, Zhou Y, Gong X and Zhang C:
MicroRNA-30a-5p inhibits the proliferation and invasion of gastric
cancer cells by targeting insulin-like growth factor 1 receptor.
Exp Ther Med. 14:173–180. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li L, Kang L, Zhao W, Feng Y, Liu W, Wang
T, Mai H, Huang J, Chen S, Liang Y, et al: miR-30a-5p suppresses
breast tumor growth and metastasis through inhibition of
LDHA-mediated Warburg effect. Cancer Lett. 400:89–98. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wei W, Yang Y, Cai J, Cui K, Li RX, Wang
H, Shang X and Wei D: MiR-30a-5p suppresses tumor metastasis of
human colorectal cancer by targeting ITGB3. Cell Physiol Biochem.
39:1165–1176. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Meng F, Wang F, Wang L, Wong SC, Cho WC
and Chan LW: MiR-30a-5p overexpression may overcome EGFR-inhibitor
resistance through regulating PI3K/AKT signaling pathway in
non-small cell lung cancer cell lines. Front Genet. 7:1972016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Y, Zhang J, Liu Y, Zhang B, Zhong F,
Wang S and Fang Z: MiR-30a-5p confers cisplatin resistance by
regulating IGF1R expression in melanoma cells. BMC Cancer.
18:4042018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang L, Zhang J, Yang X, Chang YW, Qi M,
Zhou Z, Zhang J and Han B: SOX4 is associated with poor prognosis
in prostate cancer and promotes epithelial-mesenchymal transition
in vitro. Prostate Cancer Prostatic Dis. 16:301–307. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Song GD, Sun Y, Shen H and Li W: SOX4
overexpression is a novel biomarker of malignant status and poor
prognosis in breast cancer patients. Tumor Biol. 36:4167–4173.
2015. View Article : Google Scholar
|
|
34
|
Han R, Huang S, Bao Y, Liu X, Peng X, Chen
Z, Wang Q, Wang J, Zhang Q, Wang T, et al: Upregulation of SOX4
antagonizes cellular senescence in esophageal squamous cell
carcinoma. Oncol Lett. 12:1367–1372. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang D, Hao T, Pan Y, Qian X and Zhou D:
Increased expression of SOX4 is a biomarker for malignant status
and poor prognosis in patients with non-small cell lung cancer. Mol
Cell Biochem. 402:75–82. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hur W, Rhim H, Jung CK, Kim JD, Bae SH,
Jang JW, Yang JM, Oh ST, Kim DG, Wang HJ, et al: SOX4
overexpression regulates the p53-mediated apoptosis in
hepatocellular carcinoma: Clinical implication and functional
analysis in vitro. Carcinogenesis. 31:1298–1307. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dai W, Xu X, Li S, Ma J, Shi Q, Guo S, Liu
L, Guo W, Xu P, He Y, et al: SOX4 promotes proliferative signals by
regulating Glycolysis through AKT activation in melanoma cells. J
Invest Dermatol. 137:2407–2416. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cheng Q, Wu J, Zhang Y, Liu X, Xu N, Zuo F
and Xu J: SOX4 promotes melanoma cell migration and invasion though
the activation of the NF-κB signaling pathway. Int J Mol Med.
40:447–453. 2017. View Article : Google Scholar : PubMed/NCBI
|
